Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cetuximab, capecitabine and irinotecan with radiotherapy before surgery for cancer of the rectum (EXCITE)

Overview

Cancer types:

Bowel (colorectal) cancer, Rectal cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at cetuximab, capecitabine and irinotecan with radiotherapy before surgery for rectal cancer that has spread into the surrounding tissues. It was supported by Cancer Research UK.

Recruitment start: 9 April 2009

Recruitment end: 24 October 2011

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Simon Gollins

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

University College London (UCL)

Other information

This is Cancer Research UK trial number CRUK/07/043.

Last reviewed: 11 Jan 2018

CRUK internal database number: 2129

Help and support